tiprankstipranks
Trending News
More News >
QuiaPEG Pharmaceuticals Holding AB (DE:99B0)
FRANKFURT:99B0
Germany Market

QuiaPEG Pharmaceuticals Holding AB (99B0) Financial Statements

Compare
0 Followers

QuiaPEG Pharmaceuticals Holding AB Financial Overview

QuiaPEG Pharmaceuticals Holding AB's market cap is currently €707.32K. The company's EPS TTM is €-0.001095228; its P/E ratio is ―; QuiaPEG Pharmaceuticals Holding AB is scheduled to report earnings on March 3, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenuekr 0.00kr 4.37Mkr 5.57Mkr 216.00Kkr 1.86M
Gross Profitkr 460.00Kkr 2.17Mkr 8.91Mkr 527.00Kkr -2.99M
Operating Incomekr -28.66Mkr -15.51Mkr -15.79Mkr -17.57Mkr -24.93M
EBITDAkr -9.71Mkr -13.43Mkr -13.98Mkr -16.01Mkr -23.67M
Net Incomekr -28.93Mkr -16.52Mkr -24.38Mkr -22.43Mkr -30.49M
Balance Sheet
Cash & Short-Term Investmentskr 2.00Kkr 101.00Kkr 2.57Mkr 5.34Mkr 8.59M
Total Assetskr 22.75Mkr 41.96Mkr 23.44Mkr 23.76Mkr 20.54M
Total Debtkr 0.00kr 20.61Mkr 15.52Mkr 17.80Mkr 15.75M
Net Debtkr -2.00Kkr 20.51Mkr 12.96Mkr 12.46Mkr 7.16M
Total Liabilitieskr 6.39Mkr 26.71Mkr 21.03Mkr 23.74Mkr 20.47M
Stockholders' Equitykr 16.35Mkr 15.25Mkr 2.41Mkr 22.00Kkr 71.00K
Cash Flow
Free Cash Flowkr -10.63Mkr -34.64Mkr -23.75Mkr -28.70Mkr -30.81M
Operating Cash Flowkr -10.17Mkr -10.27Mkr -18.18Mkr -20.11Mkr -28.31M
Investing Cash Flowkr -460.00Kkr -24.37Mkr -5.57Mkr -8.59Mkr -2.50M
Financing Cash Flowkr 10.53Mkr 32.17Mkr 20.98Mkr 25.46Mkr 34.86M
Currency in SEK

QuiaPEG Pharmaceuticals Holding AB Earnings and Revenue History

QuiaPEG Pharmaceuticals Holding AB Debt to Assets

QuiaPEG Pharmaceuticals Holding AB Cash Flow

QuiaPEG Pharmaceuticals Holding AB Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis